Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets, Volume 17 - Number 1

HIV-1 Matrix Protein p17 and its Receptors

, 17(1): 23 - 32

Francesca Caccuri, Stefania Marsico, Simona Fiorentini, Arnaldo Caruso and Cinzia Giagulli

DOI: 10.2174/1389450116666150825110840

The Contribution of Extracellular Nef to HIV-Induced Pathogenesis

, 17(1): 46 - 53

Eleonora Olivetta, Claudia Arenaccio, Francesco Manfredi, Simona Anticoli and Maurizio Federico

DOI: 10.2174/1389450116666151001110126

Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?

, 17(1): 54 - 64

Erica Giuliani, Lia Vassena, Cristina Cerboni and Margherita Doria

DOI: 10.2174/1389450116666150630110329

The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

, 17(1): 76 - 110

Daniela Angela Covino, Michela Sabbatucci and Laura Fantuzzi

DOI: 10.2174/138945011701151217110917

HIV-1 gp120: A Target for Therapeutics and Vaccine Design

, 17(1): 122 - 135

Claudia Cicala, Fatima Nawaz, Katija Jelicic, James Arthos and Anthony S. Fauci

DOI: 10.2174/1389450116666150825120735


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog